Er-Kim To Distribute Puma's Breast Cancer Drug NERLYNX In Eastern Europe And Central Asia
30/4 23:48
(RTTNews) - Er-Kim, a pharmaceutical company focused on bringing innovative therapies to the EMEA region, Wednesday has entered into a commercialization agreement with Puma Biotechnology, Inc. (PBYI) for NERLYNX (neratinib)....